Hathal Haddad, Editorial Board Member of OncoDaily Medical Journal and Head of Interventional Radiotherapy Unit at the Department of Radiation Oncology at University Hospital Tübingen, shared European Society for Radiotherapy and Oncology (ESTRO)’s post on LinkedIn, adding:
“Interventional Radiotherapy for lip cancer – excellent outcomes from the Dutch experience
A multicentre study from Netherlands reports 97% local control, very low toxicity, and high patient satisfaction for lip carcinoma treated with brachytherapy.
Strong evidence that interventional radiotherapy offers precise, organ-preserving, and patient-centred treatment — exactly what we strive for in everyday head & neck practice.”
Quoting European Society for Radiotherapy and Oncology (ESTRO)’s post:
“Brachytherapy for lip cancer: the Dutch experience
This multicentre study from The Netherlands shows that brachytherapy for lip carcinoma delivers excellent local control (97%), very low toxicity, and high patient satisfaction, across techniques and regimens.”
Title: Brachytherapy (interventional radiotherapy) for lip carcinoma: excellent local control, low toxicity profile, and high patient satisfaction – the Dutch experience from four brachytherapy-dedicated head-and-neck cancer centres (IR-Lip study)
Authors: Abrahim Al-Mamgani, Gerda M. Verduijn, Ellen Zwijnenburg, Willem H. Schreuder, Aniel Sewnaik, Willem Weijs, Johhanes A. Rijken, Lisa Tans, Homan Dehnad, Lia Verhoef, Robert van Es, Arash Navran, Luc Karssemakers, Mischa de Ridder
Other articles featuring Hathal Haddad.